Literature DB >> 6248875

Persistence of increased platelet cyclic AMP induced by prostaglandin E1 after removal of the hormone.

A K Sinha, R W Colman.   

Abstract

Prostaglandin E1 (PGE1) covalently linked to omega-NH2-hexyl-agarose (PGE1-hexyl-agarose) stimulates the activity of human platelet adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] 3-fold over control level at 60 sec when stirred at 1200 rpm at 37 degrees C. The time course exhibited a lag phase of 20 sec, a rapid increase to a maximum plateau between 60 and 80 sec, and a more gradual decrease to basal level at about 120 sec. During this entire period of incubation PGE1-hexyl-agarose could be easily separated; therefore it bound only transiently to the platelet. No prostaglandin(s) were found to be released into plasma. The stimulation of adenylate cyclase activity by the insolubilized hormone was dependent on the rate of collision as influenced by the speed of stirring. Removal of the insoluble PGE1 before the end of the lag period (10 sec) prevented the increase of adenylate cyclase. In contrast, separation of PGE1-hexyl-agarose from platelets by filtration after the lag period (at 30 or 40 sec) allowed the stimulation of the enzymatic activity to continue to completion in the absence of the hormone. The results suggest that PGE1 initiates molecular events leading to an increase of adenylate cyclase that do not require its continued presence for maintenance of the stimulated state.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248875      PMCID: PMC349523          DOI: 10.1073/pnas.77.5.2946

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  The regulatory control of beta-receptor dependent adenylate cyclase.

Authors:  A Levitzki; N Sevilla; M L Steer
Journal:  J Supramol Struct       Date:  1976

2.  Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.

Authors:  E W Salzman; L Levine
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

3.  Methotrexate-agarose in the purification of dihydrofolate reductase.

Authors:  B T Kaufman
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

5.  Adenyl cyclase activity in human platelets.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

6.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action.

Authors:  M Rodbell; L Birnbaumer; S L Pohl; H M Krans
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants.

Authors:  A A Spector; J E Fletcher; J D Ashbrook
Journal:  Biochemistry       Date:  1971-08-17       Impact factor: 3.162

8.  The effect of prostaglandin E1 on platelet function in vitro and in vivo.

Authors:  R L Kinlough-Rathbone; M A Packham; J F Mustard
Journal:  Br J Haematol       Date:  1970-11       Impact factor: 6.998

9.  Hydrophobic chromatography.

Authors:  S Shaltiel
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

10.  Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.

Authors:  G Ball; G G Brereton; M Fulwood; D M Ireland; P Yates
Journal:  Biochem J       Date:  1970-12       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.